RISS 학술연구정보서비스

검색

인기 검색어

    다국어 입력

    http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

    변환된 중국어를 복사하여 사용하시면 됩니다.

    예시)
    • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
    • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
    닫기
    KCI등재후보

    合歡皮 추출물의 항산화활성 및 혈관계에 미치는 영향에 대한 연구 = A study on antioxidative and Antihypertensive Effects of the Water Extracts of Albizzia julibrissin

    한글로보기

    https://www.riss.kr/link?id=A103929505

    • 0

      상세조회
    • 0

      다운로드
    서지정보 열기
    • 내보내기
    • 내책장담기
    • 공유하기
    • 오류접수

    부가정보

    다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

    Albizzia julibrissin have long been used for clinical therapy associated especially with menopausal symptoms in Korea. To provide a scientific rationale for such use, we have investigated the antioxidant and vasorelaxant effects of Albizzia julibrissin. Antioxidant activity was measured using the , -diphenyl- -picrylhydrazyl (DPPH) radical scavenging and superoxide anion radical scavenging methods. The water extracts of Albizzia julibrissin (AJ-Ex) produced a dose-dependent radical scavenging activity against DPPH and superoxide anion radical.
    The vasorelaxant effects of Albizzia julibrissin and its possible mechanism of action were investigated on the vasomotor tone of the rat thoracic aorta rings in an organ bath. The extracts produced a dose-dependent transient relaxation in the endothelium-intact rat aorta precontracted with norepinephrine (NE). This relaxant effect was significantly attenuated by removal of the endothelium and also by treatment with such nitric oxide (NO) synthase inhibitor L-NNA (10 M). Neither a prostacycline synthase inhibitor, indomethacin (10 M), nor a muscarinic receptor antagonist, atropine (10 M), altered the AJ-Ex induced endothelium-dependent relaxation.
    In conclusion, these antioxidant and vasorelaxant effects of the extracts may contribute to the beneficial effects in postmenopausal women.
    번역하기

    Albizzia julibrissin have long been used for clinical therapy associated especially with menopausal symptoms in Korea. To provide a scientific rationale for such use, we have investigated the antioxidant and vasorelaxant effects of Albizzia julibrissi...

    Albizzia julibrissin have long been used for clinical therapy associated especially with menopausal symptoms in Korea. To provide a scientific rationale for such use, we have investigated the antioxidant and vasorelaxant effects of Albizzia julibrissin. Antioxidant activity was measured using the , -diphenyl- -picrylhydrazyl (DPPH) radical scavenging and superoxide anion radical scavenging methods. The water extracts of Albizzia julibrissin (AJ-Ex) produced a dose-dependent radical scavenging activity against DPPH and superoxide anion radical.
    The vasorelaxant effects of Albizzia julibrissin and its possible mechanism of action were investigated on the vasomotor tone of the rat thoracic aorta rings in an organ bath. The extracts produced a dose-dependent transient relaxation in the endothelium-intact rat aorta precontracted with norepinephrine (NE). This relaxant effect was significantly attenuated by removal of the endothelium and also by treatment with such nitric oxide (NO) synthase inhibitor L-NNA (10 M). Neither a prostacycline synthase inhibitor, indomethacin (10 M), nor a muscarinic receptor antagonist, atropine (10 M), altered the AJ-Ex induced endothelium-dependent relaxation.
    In conclusion, these antioxidant and vasorelaxant effects of the extracts may contribute to the beneficial effects in postmenopausal women.

    더보기

    다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

    Albizzia julibrissin have long been used for clinical therapy associated especially with menopausal symptoms in Korea. To provide a scientific rationale for such use, we have investigated the antioxidant and vasorelaxant effects of Albizzia julibrissin. Antioxidant activity was measured using the , -diphenyl- -picrylhydrazyl (DPPH) radical scavenging and superoxide anion radical scavenging methods. The water extracts of Albizzia julibrissin (AJ-Ex) produced a dose-dependent radical scavenging activity against DPPH and superoxide anion radical.
    The vasorelaxant effects of Albizzia julibrissin and its possible mechanism of action were investigated on the vasomotor tone of the rat thoracic aorta rings in an organ bath. The extracts produced a dose-dependent transient relaxation in the endothelium-intact rat aorta precontracted with norepinephrine (NE). This relaxant effect was significantly attenuated by removal of the endothelium and also by treatment with such nitric oxide (NO) synthase inhibitor L-NNA (10 M). Neither a prostacycline synthase inhibitor, indomethacin (10 M), nor a muscarinic receptor antagonist, atropine (10 M), altered the AJ-Ex induced endothelium-dependent relaxation.
    In conclusion, these antioxidant and vasorelaxant effects of the extracts may contribute to the beneficial effects in postmenopausal women.
    번역하기

    Albizzia julibrissin have long been used for clinical therapy associated especially with menopausal symptoms in Korea. To provide a scientific rationale for such use, we have investigated the antioxidant and vasorelaxant effects of Albizzia julibrissi...

    Albizzia julibrissin have long been used for clinical therapy associated especially with menopausal symptoms in Korea. To provide a scientific rationale for such use, we have investigated the antioxidant and vasorelaxant effects of Albizzia julibrissin. Antioxidant activity was measured using the , -diphenyl- -picrylhydrazyl (DPPH) radical scavenging and superoxide anion radical scavenging methods. The water extracts of Albizzia julibrissin (AJ-Ex) produced a dose-dependent radical scavenging activity against DPPH and superoxide anion radical.
    The vasorelaxant effects of Albizzia julibrissin and its possible mechanism of action were investigated on the vasomotor tone of the rat thoracic aorta rings in an organ bath. The extracts produced a dose-dependent transient relaxation in the endothelium-intact rat aorta precontracted with norepinephrine (NE). This relaxant effect was significantly attenuated by removal of the endothelium and also by treatment with such nitric oxide (NO) synthase inhibitor L-NNA (10 M). Neither a prostacycline synthase inhibitor, indomethacin (10 M), nor a muscarinic receptor antagonist, atropine (10 M), altered the AJ-Ex induced endothelium-dependent relaxation.
    In conclusion, these antioxidant and vasorelaxant effects of the extracts may contribute to the beneficial effects in postmenopausal women.

    더보기

    참고문헌 (Reference)

    1 "한국여성에서 심혈관계 위험인자에 대한 연구" 5 (5): 48-54, 1999

    2 "오배자의 항산화 활성성분 및 자유라디칼 소거 효과" 31 (31): 185-189, 2000

    3 "오배자의 항산화 및 자유라디칼 소거 효과" 6 (6): 181-187, 1998

    4 "심혈관질환의 분자세포생물학 : 임상심장학" 고려의학 76-83, 1998

    5 "심혈관계에서 산화질소의 병태생리학적 역할" 46-48, 1995

    6 "산화질소 생성의 생화학" 41-45, 1995

    7 "사망원인통계" 통계청

    8 "된장으로부터 Angiotensin Converting Enzyme 활성 저해물질의 정제" 441-446, 1994

    9 "韓醫婦人科學(上)" 정담 242-243, 2002

    10 "旱蓮草 및 二至丸의 항산화활성 및 혈압에 미치는 영향에 관한 연구" 2003

    1 "한국여성에서 심혈관계 위험인자에 대한 연구" 5 (5): 48-54, 1999

    2 "오배자의 항산화 활성성분 및 자유라디칼 소거 효과" 31 (31): 185-189, 2000

    3 "오배자의 항산화 및 자유라디칼 소거 효과" 6 (6): 181-187, 1998

    4 "심혈관질환의 분자세포생물학 : 임상심장학" 고려의학 76-83, 1998

    5 "심혈관계에서 산화질소의 병태생리학적 역할" 46-48, 1995

    6 "산화질소 생성의 생화학" 41-45, 1995

    7 "사망원인통계" 통계청

    8 "된장으로부터 Angiotensin Converting Enzyme 활성 저해물질의 정제" 441-446, 1994

    9 "韓醫婦人科學(上)" 정담 242-243, 2002

    10 "旱蓮草 및 二至丸의 항산화활성 및 혈압에 미치는 영향에 관한 연구" 2003

    11 "山査의 내피세포 의존성 혈관이완효과기전에 대한 연구" 18 (18): 169-180, 2003

    12 "對譯 東醫寶鑑" 법인문화사 1999

    13 "Use of alternative and complementary medicine in menopause" 79 : 195-207, 2002

    14 "Use of a free radical method to evaluate antioxidant activity" 25-30, 1985

    15 "Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells" 360 : 291-293, 1995

    16 "The influence of menopause on blood pressure" 427-433, 1989

    17 "Spectrophotometric assay and properties of the angiotensin converting enzyme of rabbit lung" 1637-1648, 1970

    18 "Risk and Benefits of Estrogen plus Progestin in healthy postmenopausal women" 288 (288): 321-333, 2002

    19 "Regulation of prostacyclin and thromboxane production by human umbilical vessels the effect of estradiol and progesterone in a superfusion model" 115-124, 1982

    20 "Protective effect of 17-beta-estradiol against the cytotoxicity of minimally oxidized LDL to cultured bovine aortic endothelial cells" 207-99 217, 1993

    21 "Preparation and assay of superoxide dismutases" 382-393, 1978

    22 "Non-hormone replacement therapy options and alternative therapies. Management of the Menopause: The hand book of the British Menopause Society, 2nd Ed" BMS Publications LTD 42-49, 1999

    23 "Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells" 94 : 1402-1407, 1996

    24 "Estrogen replacement in menopause" 81 : 3829-3838, 1996

    25 "Estrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women" and o'can (and o'can): 269-343 270, 1994

    26 "Endothelium independent relaxation of human coronary arteries by 17 -estradiol in vitro" 1939-19421993

    27 "Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial" 291 (291): 1769-1771, 2004apr

    28 "Coronary heart disease risk factors in relation to the menopause" 889-896, 1992

    29 "Cardiovascular disease and postmenopausal hormone treatment in women" 19 : 55-62, 2000

    더보기

    동일학술지(권/호) 다른 논문

    분석정보

    View

    상세정보조회

    0

    Usage

    원문다운로드

    0

    대출신청

    0

    복사신청

    0

    EDDS신청

    0

    동일 주제 내 활용도 TOP

    더보기

    주제

    연도별 연구동향

    연도별 활용동향

    연관논문

    연구자 네트워크맵

    공동연구자 (7)

    유사연구자 (20) 활용도상위20명

    인용정보 인용지수 설명보기

    학술지 이력

    학술지 이력
    연월일 이력구분 이력상세 등재구분
    2027 평가 재인증평가 신청대상 (재인증)
    2021-01-01 등재 등재학술지 유지 (재인증) KCI등재
    2018-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2015-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2011-01-01 등재 등재 1차 FAIL (등재유지) KCI등재
    2009-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2006-01-01 등재 등재학술지 선정 (등재후보2차) KCI등재
    2005-01-01 등재 등재후보 1차 PASS (등재후보1차) KCI등재후보
    2004-01-01 등재 등재후보학술지 유지 (등재후보1차) KCI등재후보
    2002-01-01 등재 등재후보학술지 선정 (신규평가) KCI등재후보
    더보기

    학술지 인용정보

    학술지 인용정보
    기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
    2016 0.38 0.38 0.4
    KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
    0.39 0.43 0.545 0.13
    더보기

    이 자료와 함께 이용한 RISS 자료

    나만을 위한 추천자료

    해외이동버튼